Drug Profile
Lysostaphin intravenous
Alternative Names: Lysostaphin IV solutionLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Nutrition 21
- Class Antibacterials; Metalloendopeptidases
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Staphylococcal infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Staphylococcal-infections in USA (IV, Liquid)
- 14 Oct 2002 Preclinical trials in Staphylococcal infections in USA (IV)
- 27 Oct 1999 Discontinued-Preclinical for Staphylococcal infections in USA (IV)